Hospital Universitario Reina Sofia -ko ikertzaileekin lankidetzan egindako argitalpenak (10)

2024

  1. Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

2022

  1. Meta-Inflammation and De Novo Lipogenesis Markers Are Involved in Metabolic Associated Fatty Liver Disease Progression in BTBR ob/ob Mice

    International Journal of Molecular Sciences, Vol. 23, Núm. 7

  2. Prospective associations between a priori dietary patterns adherence and kidney function in an elderly Mediterranean population at high cardiovascular risk

    European Journal of Nutrition, Vol. 61, Núm. 6, pp. 3095-3108

2021

  1. Longitudinal changes in adherence to the portfolio and DASH dietary patterns and cardiometabolic risk factors in the PREDIMED-Plus study

    Clinical Nutrition, Vol. 40, Núm. 5, pp. 2825-2836

  2. Protective role of nrf2 in renal disease

    Antioxidants, Vol. 10, Núm. 1, pp. 1-31

2020

  1. Lipotoxicity and diabetic nephropathy: Novel mechanistic insights and therapeutic opportunities

    International Journal of Molecular Sciences, Vol. 21, Núm. 7

  2. Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy

    International Journal of Molecular Sciences, Vol. 21, Núm. 11

2019

  1. Adherence to an Energy-restricted Mediterranean Diet Score and Prevalence of Cardiovascular Risk Factors in the PREDIMED-Plus: A Cross-sectional Study

    Revista Espanola de Cardiologia, Vol. 72, Núm. 11, pp. 925-934

  2. Cohort profile: Design and methods of the PREDIMED-Plus randomized trial

    International Journal of Epidemiology, Vol. 48, Núm. 2, pp. 387-388o

2018

  1. Higher proportion of non-1-84 PTH fragments in peritoneal dialysis patients compared to hemodialysis patients using solutions containing 1.75 mmol/l calcium

    Frontiers in Physiology, Vol. 9, Núm. NOV